NVO•benzinga•
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
Summary
Pfizer has discontinued Beqvez for hemophilia B due to low patient demand and will focus on alternative treatments, including its approved therapy, Hympavzi.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 21, 2025 by benzinga